{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:10:33Z","timestamp":1783649433155,"version":"3.55.0"},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2016,1,30]],"date-time":"2016-01-30T00:00:00Z","timestamp":1454112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Infectious Dis"],"published-print":{"date-parts":[[2016,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Latent tuberculosis infection (<jats:styled-content style=\"fixed-case\">LTBI<\/jats:styled-content>) screening prior to solid organ transplantation is standard of care. Quanti<jats:styled-content style=\"fixed-case\">FERON<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">TB<\/jats:styled-content> Gold In\u2010Tube (<jats:styled-content style=\"fixed-case\">QFT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">GIT<\/jats:styled-content>) test is the preferred diagnostic test for renal transplant candidates (<jats:styled-content style=\"fixed-case\">RTC<\/jats:styled-content>). <jats:styled-content style=\"fixed-case\">QFT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">GIT<\/jats:styled-content> reversions and the potential delay of living\u2010donor kidney transplantation (<jats:styled-content style=\"fixed-case\">LDKT<\/jats:styled-content>) because of <jats:styled-content style=\"fixed-case\">QFT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">GIT<\/jats:styled-content> positivity have not been examined previously in <jats:styled-content style=\"fixed-case\">RTC<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We evaluated the prevalence of positive <jats:styled-content style=\"fixed-case\">QFT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">GIT<\/jats:styled-content> in <jats:styled-content style=\"fixed-case\">RTC<\/jats:styled-content> from January 1 through December 31, 2011. In addition, we examined the demographic and renal disease data differences between <jats:styled-content style=\"fixed-case\">QFT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">GIT<\/jats:styled-content>\u2010positive and \u2010negative patients, changes in <jats:styled-content style=\"fixed-case\">QFT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">GIT<\/jats:styled-content> results, and positive <jats:styled-content style=\"fixed-case\">QFT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">GIT<\/jats:styled-content> results reverting to negative. Lastly, we evaluated if <jats:styled-content style=\"fixed-case\">QFT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">GIT<\/jats:styled-content>\u2010positive patients were less likely to undergo <jats:styled-content style=\"fixed-case\">LDKT<\/jats:styled-content> within 6 months of <jats:styled-content style=\"fixed-case\">QFT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">GIT<\/jats:styled-content> testing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 722 <jats:styled-content style=\"fixed-case\">RTC<\/jats:styled-content> were analyzed, 16% of whom had positive <jats:styled-content style=\"fixed-case\">QFT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">GIT<\/jats:styled-content>. The <jats:styled-content style=\"fixed-case\">QFT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">GIT<\/jats:styled-content>\u2010positive patients were more likely to be older and foreign\u2010born, <jats:italic>P<\/jats:italic> &lt; 0.0001. Haitians had the highest prevalence. Of the 119 <jats:styled-content style=\"fixed-case\">QFT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">GIT<\/jats:styled-content>\u2010positive patients, 25% had low\/intermediate\u2010positive results and were more likely to revert to negative, compared with patients with high\u2010positive <jats:styled-content style=\"fixed-case\">QFT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">GIT<\/jats:styled-content> results (50% vs. 0%, <jats:italic>P<\/jats:italic> = 0.01). A trend was seen toward fewer <jats:styled-content style=\"fixed-case\">QFT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">GIT<\/jats:styled-content>\u2010positive patients undergoing <jats:styled-content style=\"fixed-case\">LDKT<\/jats:styled-content>, compared with <jats:styled-content style=\"fixed-case\">QFT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">GIT<\/jats:styled-content>\u2010negative patients (0% vs. 3%, <jats:italic>P<\/jats:italic> = 0.09).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our high prevalence was likely a result of the high number of foreign\u2010born <jats:styled-content style=\"fixed-case\">RTC<\/jats:styled-content>. Half of our small subset of low\/intermediate\u2010positive <jats:styled-content style=\"fixed-case\">QFT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">GIT<\/jats:styled-content> patients reverted to negative. <jats:styled-content style=\"fixed-case\">QFT<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">GIT<\/jats:styled-content>\u2010positive patients were more likely to have their <jats:styled-content style=\"fixed-case\">LDKT<\/jats:styled-content> delayed.<\/jats:p><\/jats:sec>","DOI":"10.1111\/tid.12476","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T08:22:02Z","timestamp":1446625322000},"page":"5-13","source":"Crossref","is-referenced-by-count":9,"title":["Demographics and prevalence of positive Quanti<scp>FERON<\/scp>\u2010<scp>TB<\/scp> Gold In\u2010Tube test in renal transplant candidates"],"prefix":"10.1111","volume":"18","author":[{"given":"J.","family":"Simkins","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases University of Miami Miller School of Medicine Miami Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kraus","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases University of Miami Miller School of Medicine Miami Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.I.","family":"Morris","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases University of Miami Miller School of Medicine Miami Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,1,30]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1085700"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1086\/427692"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12100"},{"issue":"3","key":"e_1_2_6_5_1","first-page":"341","article-title":"Tuberculosis in California dialysis patients","volume":"8","author":"Ahmed AT","year":"2004","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1005750"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2011.00666.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.22203"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7210617"},{"key":"e_1_2_6_10_1","unstructured":"United States Census Bureau.Miami\u2010Dade County Florida. Available at:http:\/\/quickfacts.census.gov\/qfd\/states\/12\/12086.html[Accessed May 14 2015]."},{"issue":"5","key":"e_1_2_6_11_1","first-page":"1","article-title":"Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection \u2013 United States, 2010","volume":"59","author":"Mazurek GH","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldp039"},{"issue":"3","key":"e_1_2_6_13_1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1155\/2012\/287181","article-title":"Interferon\u2010gamma release assays are a better tuberculosis screening test for hemodialysis patients: a study and review of the literature","volume":"23","author":"Grant J","year":"2012","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2012.07.019"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1086\/670635"},{"issue":"11","key":"e_1_2_6_16_1","first-page":"229","article-title":"Trends in tuberculosis \u2013 United States, 2013","volume":"63","author":"Alami NN","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_6_17_1","unstructured":"Pan American Health Organization.Regional office of the World Health Organization Tuberculosis in the Region of the Americas Regional Report 2012. Epidemiology Control and Financing. Available at:http:\/\/www.paho.org\/hq\/index.php?option=com_docman&task=doc_view&gid=22953&Itemid[Accessed May 14 2015]."},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050152"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114442"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-9-81"},{"key":"e_1_2_6_21_1","unstructured":"World Health Organization(2011)Tuberculosis and diabetes. Available at:http:\/\/www.who.int\/tb\/publications\/diabetes_tb.pdf[Accessed May 14 2015]."},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu119"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1309\/LMLSJ4BVXS66WJHS"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit418"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201310-378OC"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2006.00595.x"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181e8a680"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200211270-00005"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103083441004"}],"container-title":["Transplant Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftid.12476","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tid.12476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T07:50:23Z","timestamp":1695541823000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tid.12476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,30]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["10.1111\/tid.12476"],"URL":"https:\/\/doi.org\/10.1111\/tid.12476","archive":["Portico"],"relation":{},"ISSN":["1398-2273","1399-3062"],"issn-type":[{"value":"1398-2273","type":"print"},{"value":"1399-3062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,30]]}}}